Table 3.
Prevalence and odds ratio of DSPN across serum 25(OH)D quartiles.
| 25(OH)D, ng/mL | n | Prevalence, % | OR (95% CI) | P |
|---|---|---|---|---|
| Q1 (8.71–22.10) | 142 | 96 | 1.00 (reference) | / |
| Q2 (22.10–25.80) | 141 | 95 | 0.85 (0.28–2.58) | 0.767 |
| Q3 (25.80–29.70) | 143 | 75 | 0.13 (0.05–0.32) | <0.001 |
| Q4 (29.70–56.60) | 143 | 31 | 0.02 (0.01–0.05) | <0.001 |
| P trend for ORs | <0.001 |
25(OH)D, 25-hydroxyvitamin D; DSPN, distal symmetric polyneuropathy; OR, odds ratio; CI, confidence interval.